ContraceptionPHARMNCT03230578
Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans
An observational study of Contraception, run by University of New Mexico at 1 site in United States.
Trial summary
The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Contraception
- What is being tested?
- Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 14 Nov 2017to 8 Jun 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Our study is qualitative and not meant to capture a representative sample of the state's population, but rather capture a diverse array of opinions regarding hormonal contraception.
Who may be able to join
- Pharmacists: actively employed and currently licensed and working in rural counties in New Mexico.
- Women: Reproductive age, 18-45 years old from rural counties in New Mexico and who are fluent in English.
Who cannot join
- Pharmacists: decline to participate or work outside the defined rural areas, not currently employed or licensed.
- Women: younger than 18 or older than 45, living in urban areas (Albuquerque and Las Cruces).
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
Read the detailed description
There are no studies examining New Mexico pharmacists' interest in prescribing hormonal contraceptives or rural New Mexican women's support for pharmacist prescribed hormonal contraceptives. However, some states where pharmacists already prescribe contraception have experienced difficulties in implementing the education, infrastructure, and financial support necessary to provide hormonal contraception in the community pharmacy setting. Nationwide, 68% of women reported that they would utilize pharmacist prescribed hormonal contraception and cited benefits such as convenient hours and locations of pharmacies. The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
- Conditions
- Contraception
- Being tested
- Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception
- Keywords
- Pharmacists, Prescriptions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pharmacists & women's perspectives on pharmacist prescribed hormonal contraceptionOther
The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
| Study group | Role | What they receive |
|---|---|---|
| Pharmacists | Actively employed and currently licensed and working in rural counties in New Mexico. Receives: Other: Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception | |
| Women | Reproductive age, 18-45 years old from rural counties in New Mexico and who are fluent in English. Receives: Other: Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pharmacist interview objective
To explore pharmacist perspectives on providing prescriptions for hormonal contraceptives, specifically identifying perceived barriers and facilitators to implementation.
Measured: 8/1/17-7/16/18
Women interview objective
1.2. To explore women's perspectives on receiving hormonal contraception prescribed by pharmacists.
Measured: 8/1/17-7/16/18
Hypothesis to be tested
Rural women and pharmacists across New Mexico will be supportive of prescriptive authority and pharmacy access to hormonal contraceptives.
Measured: 8/1/17-7/16/18
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2017
- Study start14 Nov 2017
- Primary completion8 Jun 2018
- Study completion8 Jun 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for ContraceptionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of New Mexico
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Eve Espey, University of New Mexico
- Investigators
- Eve Espey, MD, Principal investigator, University of New Mexico, OB/GYN
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03230578
- Sponsor's protocol ID
- 17-237
- Acronym
- PHARM
- Status last verified
- Oct 2018
- First submitted
- 24 Jul 2017
- Last updated
- 15 Oct 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Herman A, McCauley G, Thaxton L, Borrego M, Sussman AL, Espey E. Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists. J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):e57-e63. doi: 10.1016/j.japh.2020.02.026. Epub 2020 Apr 2.
PubMed 32249171
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans
- ClinicalTrials.gov ID
- NCT03230578
- Acronym / sponsor ID
- PHARM / 17-237
- Conditions
- Contraception
- Keywords
- Pharmacists, Prescriptions
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- University of New MexicoUniversity, hospital or other
- Study start
- 14 Nov 2017 (actual)
- Primary completion
- 8 Jun 2018 (actual)
- Study completion
- 8 Jun 2018 (actual)
- First posted
- 26 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
Detailed description
There are no studies examining New Mexico pharmacists' interest in prescribing hormonal contraceptives or rural New Mexican women's support for pharmacist prescribed hormonal contraceptives. However, some states where pharmacists already prescribe contraception have experienced difficulties in implementing the education, infrastructure, and financial support necessary to provide hormonal contraception in the community pharmacy setting. Nationwide, 68% of women reported that they would utilize pharmacist prescribed hormonal contraception and cited benefits such as convenient hours and locations of pharmacies. The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Pharmacists | – | Other: Pharmacists & women's perspectives on pharmacist prescribed hormonal contraceptionActively employed and currently licensed and working in rural counties in New Mexico. |
| Women | – | Other: Pharmacists & women's perspectives on pharmacist prescribed hormonal contraceptionReproductive age, 18-45 years old from rural counties in New Mexico and who are fluent in English. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Our study is qualitative and not meant to capture a representative sample of the state's population, but rather capture a diverse array of opinions regarding hormonal contraception.
Key inclusion criteria (2 listed)
- Pharmacists: actively employed and currently licensed and working in rural counties in New Mexico.
- Women: Reproductive age, 18-45 years old from rural counties in New Mexico and who are fluent in English.
Key exclusion criteria (2 listed)
- Pharmacists: decline to participate or work outside the defined rural areas, not currently employed or licensed.
- Women: younger than 18 or older than 45, living in urban areas (Albuquerque and Las Cruces).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pharmacists & women's perspectives on pharmacist prescribed hormonal contraceptionThe goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program. | Other | Pharmacists, Women |
Primary outcome
Pharmacist interview objective
Time frame: 8/1/17-7/16/18
To explore pharmacist perspectives on providing prescriptions for hormonal contraceptives, specifically identifying perceived barriers and facilitators to implementation.
Women interview objective
Time frame: 8/1/17-7/16/18
1.2. To explore women's perspectives on receiving hormonal contraception prescribed by pharmacists.
Hypothesis to be tested
Time frame: 8/1/17-7/16/18
Rural women and pharmacists across New Mexico will be supportive of prescriptive authority and pharmacy access to hormonal contraceptives.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2018.
- Derived from this study: PubMed 32249171Herman A, McCauley G, Thaxton L, Borrego M, Sussman AL, Espey E. Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists. J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):e57-e63. doi: 10.1016/j.japh.2020.02.026. Epub 2020 Apr 2.
Related trials for Contraception
Enrolling by invitation
Flo Digital Contraceptive Study
Contraception Use
Recruiting
Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact Lab
Reproductive Health, Sexual Health
RecruitingPhase 4
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Sickle Cell Disease (SCD), Vaso-Occlusive Pain Episode in Sickle Cell Disease
Not yet recruitingObservational study
FLOW: Influence of the Menstrual Cycle on Alcohol Use in Women
Alcohol Use, Alcohol Consumption
Not yet recruiting
Impact of Gender-Transformative Interventions on Contraceptive Use and Reproductive Autonomy in Somalia
Contraceptive Behavior, Social Norms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eve Espey, MD principal investigator
University of New Mexico, OB/GYN
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Contraception, run by University of New Mexico at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pharmacist interview objective (time frame: 8/1/17-7/16/18). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03230578, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2018.